IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease
- PMID: 16251240
- DOI: 10.1681/ASN.2005030297
IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease
Abstract
IL-10 is a pluripotent cytokine that plays a pivotal role in the regulation of immune and inflammatory responses. Whereas short-term administration of IL-10 has shown benefit in acute glomerulonephritis, no studies have addressed the potential benefits of IL-10 in chronic renal disease. Chronically elevated blood levels of IL-10 in rats were achieved by administration of a recombinant adeno-associated virus serotype 1 IL-10 (rAAV1-IL-10) vector. Control rats were given a similar dose of rAAV1-GFP. Four weeks after injection, IL-10 levels in serum were measured by ELISA, and chronic renal disease was induced by a 5/6 nephrectomy (n = 6 in each group). Eight weeks later, rats were killed and renal tissue was obtained for RNA, protein, and immunohistochemical analysis. Serum levels of IL-10 were 12-fold greater in the rAAV1-IL-10 group by 4 wk after rAAV1-IL-10 administration (345 +/- 169 versus 28 +/- 15 pg/ml; P = 0.001), and levels were maintained throughout the experiment. rAAV1-IL-10 treatment resulted in less proteinuria (P < 0.05), lower serum creatinine (P < 0.05), and higher creatinine clearances (P < 0.01) compared with rAAV1-GFP-treated rats. Renal interstitial infiltration was significantly attenuated by rAAV1-IL-10 administration as assessed by numbers of CD4+, CD8+, monocyte-macrophages (ED-1+) and dendritic (OX-62+) cells (P < 0.05), and this correlated with reductions in the renal expression of monocyte (renal monocyte chemoattractant protein-1 mRNA and protein) and T cell (RANTES mRNA) chemokines. rAAV1-IL-10 administration decreased mRNA levels of IFN-gamma and IL-2 in the kidney. The reduction in inflammatory cells was associated with a significant reduction in glomerulosclerosis and interstitial fibrosis. It is concluded that IL-10 blocks inflammation and improves renal function in this model of chronic renal disease. The feasibility of long-term overexpression of a gene using the AAV serotype 1 vector system in a model of renal disease is also demonstrated.
Similar articles
-
Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.J Am Soc Nephrol. 2004 Nov;15(11):2868-81. doi: 10.1097/01.ASN.0000141962.44300.3A. J Am Soc Nephrol. 2004. PMID: 15504940
-
Macrophages contribute to the initiation of ischaemic acute renal failure in rats.Nephrol Dial Transplant. 2006 May;21(5):1231-9. doi: 10.1093/ndt/gfk047. Epub 2006 Jan 12. Nephrol Dial Transplant. 2006. PMID: 16410269
-
Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae.J Rheumatol. 2002 Sep;29(9):1827-35. J Rheumatol. 2002. PMID: 12233874
-
The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function.J Nephrol. 2003 Mar-Apr;16(2):179-85. J Nephrol. 2003. PMID: 12768064 Review.
-
The role of tubulointerstitial inflammation in the progression of chronic renal failure.Nephron Clin Pract. 2010;116(2):c81-8. doi: 10.1159/000314656. Epub 2010 May 22. Nephron Clin Pract. 2010. PMID: 20502043 Review.
Cited by
-
The Nephroprotective Effects of the Allogeneic Transplantation with Mesenchymal Stromal Cells Were Potentiated by ω3 Stimulating Up-Regulation of the PPAR-γ.Pharmaceuticals (Basel). 2023 Oct 18;16(10):1484. doi: 10.3390/ph16101484. Pharmaceuticals (Basel). 2023. PMID: 37895955 Free PMC article.
-
Chronic treatment with IL-25 increases renal M2 macrophages and reduces renal injury in obese Dahl salt-sensitive rats during the prepubescent stage.Am J Physiol Renal Physiol. 2023 Jul 1;325(1):F87-F98. doi: 10.1152/ajprenal.00209.2022. Epub 2023 May 11. Am J Physiol Renal Physiol. 2023. PMID: 37167270
-
Engineered Bone Marrow Stem Cell-Sheets Alleviate Renal Damage in a Rat Chronic Glomerulonephritis Model.Int J Mol Sci. 2023 Feb 13;24(4):3711. doi: 10.3390/ijms24043711. Int J Mol Sci. 2023. PMID: 36835123 Free PMC article.
-
Senescent macrophages alter fibroblast fibrogenesis in response to SARS-CoV-2 infection.NeuroImmune Pharm Ther. 2022 Mar 25;1(1):37-42. doi: 10.1515/nipt-2022-0003. Epub 2022 Aug 5. NeuroImmune Pharm Ther. 2022. PMID: 36534613 Free PMC article.
-
Interleukin-10 Protects against Ureteral Obstruction-Induced Kidney Fibrosis by Suppressing Endoplasmic Reticulum Stress and Apoptosis.Int J Mol Sci. 2022 Sep 14;23(18):10702. doi: 10.3390/ijms231810702. Int J Mol Sci. 2022. PMID: 36142626 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
